C1QL2
gene geneOn this page
Also known as CTRP10C1QTNF10
Summary
C1QL2 (complement C1q like 2, HGNC:24181) is a protein-coding gene on chromosome 2q14.2, encoding Complement C1q-like protein 2 (Q7Z5L3). May regulate the number of excitatory synapses that are formed on hippocampus neurons.
Predicted to enable identical protein binding activity. Predicted to be involved in maintenance of synapse structure and trans-synaptic signaling, modulating synaptic transmission. Predicted to be located in extracellular region. Predicted to be part of protein-containing complex. Predicted to be active in obsolete extracellular space; synapse; and synaptic cleft.
Source: NCBI Gene 165257 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 46 total — 4 pathogenic, 1 likely-pathogenic
- GTEx eGene: eQTL in 7 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.42 (unconstrained)
- MANE Select transcript:
NM_182528
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24181 |
| Approved symbol | C1QL2 |
| Name | complement C1q like 2 |
| Location | 2q14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CTRP10, C1QTNF10 |
| Ensembl gene | ENSG00000144119 |
| Ensembl biotype | protein_coding |
| OMIM | 614330 |
| Entrez | 165257 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
MANE Select: ENST00000272520
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000272520, ENST00000850649, ENST00001137887
RefSeq mRNA: 1 — MANE Select: NM_182528
NM_182528
CCDS: CCDS42737
Canonical transcript exons
ENST00000272520 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000963674 | 119157586 | 119158751 |
| ENSE00000963675 | 119156243 | 119156981 |
Expression profiles
Bgee: expression breadth broad, 51 present calls, max score 86.01.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4760 / max 49.5731, expressed in 133 samples.
Highest expression (Bgee): temporal lobe, amygdala, Ammon’s horn, superior frontal gyrus, anterior cingulate cortex.
Genetic regulation across tissues (GTEx eQTL / sQTL)
C1QL2 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
7 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Skin Sun Exposed Lower leg | eqtl | 4.1e-21 | +0.43 | 2:119160062:G:A |
| Brain Hippocampus | eqtl | 1.4e-06 | -0.25 | 2:119171362:C:A |
| Skin Not Sun Exposed Suprapubic | eqtl | 7.8e-05 | -0.26 | 2:119217204:G:A |
| Thyroid | eqtl | 1.3e-02 | +0.82 | 2:118346898:G:T |
| Brain Cerebellar Hemisphere | eqtl | 1.4e-02 | -0.58 | 2:119167246:C:T |
| Artery Coronary | eqtl | 3.7e-02 | -0.41 | 2:119269231:C:CA |
| Brain Caudate basal ganglia | eqtl | 4.4e-02 | +0.19 | 2:119170683:G:A |
FANTOM5 promoters
7 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 30404 | 0.2769 | 96 |
| 30408 | 0.0577 | 31 |
| 30406 | 0.0459 | 21 |
| 30407 | 0.0384 | 19 |
| 30403 | 0.0383 | 26 |
| 30405 | 0.0125 | 2 |
| 30409 | 0.0062 | 2 |
Top tissues by expression
showing 100 of 116 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| temporal lobe | UBERON:0001871 | 86.01 | gold quality |
| amygdala | UBERON:0001876 | 85.99 | gold quality |
| Ammon’s horn | UBERON:0001954 | 85.24 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 81.35 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 81.34 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 80.54 | gold quality |
| cerebral cortex | UBERON:0000956 | 79.78 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 79.63 | gold quality |
| right frontal lobe | UBERON:0002810 | 79.58 | gold quality |
| hypothalamus | UBERON:0001898 | 79.38 | gold quality |
| nucleus accumbens | UBERON:0001882 | 78.47 | gold quality |
| frontal cortex | UBERON:0001870 | 78.26 | gold quality |
| primary visual cortex | UBERON:0002436 | 77.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.09 | gold quality |
| putamen | UBERON:0001874 | 74.58 | gold quality |
| caudate nucleus | UBERON:0001873 | 74.44 | gold quality |
| substantia nigra | UBERON:0002038 | 74.25 | gold quality |
| brain | UBERON:0000955 | 72.10 | gold quality |
| ventricular zone | UBERON:0003053 | 67.13 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 65.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 59.37 | gold quality |
| ganglionic eminence | UBERON:0004023 | 59.02 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 57.43 | gold quality |
| cerebellum | UBERON:0002037 | 56.87 | gold quality |
| cerebellar cortex | UBERON:0002129 | 56.73 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 56.61 | gold quality |
| skin of leg | UBERON:0001511 | 46.00 | gold quality |
| zone of skin | UBERON:0000014 | 43.48 | gold quality |
| adenohypophysis | UBERON:0002196 | 42.45 | gold quality |
| lymph node | UBERON:0000029 | 41.87 | silver quality |
| skin of abdomen | UBERON:0001416 | 40.23 | gold quality |
| cortical plate | UBERON:0005343 | 39.94 | gold quality |
| bone marrow cell | CL:0002092 | 39.89 | gold quality |
| pituitary gland | UBERON:0000007 | 39.08 | gold quality |
| mucosa of stomach | UBERON:0001199 | 38.63 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 37.45 | gold quality |
| apex of heart | UBERON:0002098 | 37.40 | silver quality |
| anatomical system | UBERON:0000467 | 37.25 | gold quality |
| multicellular organism | UBERON:0000468 | 37.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| heart left ventricle | UBERON:0002084 | 37.17 | gold quality |
| cortex of kidney | UBERON:0001225 | 36.53 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 35.85 | gold quality |
| corpus callosum | UBERON:0002336 | 35.51 | gold quality |
| bone marrow | UBERON:0002371 | 33.65 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| right lobe of liver | UBERON:0001114 | 33.32 | silver quality |
| tonsil | UBERON:0002372 | 33.12 | gold quality |
| heart | UBERON:0000948 | 32.66 | silver quality |
| muscle tissue | UBERON:0002385 | 32.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| left ovary | UBERON:0002119 | 32.10 | silver quality |
| muscle of leg | UBERON:0001383 | 31.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 31.87 | gold quality |
| body of pancreas | UBERON:0001150 | 31.84 | gold quality |
| pancreas | UBERON:0001264 | 31.56 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| tibial artery | UBERON:0007610 | 30.47 | gold quality |
| popliteal artery | UBERON:0002250 | 30.46 | gold quality |
| blood | UBERON:0000178 | 30.40 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.67 | gold quality |
| placenta | UBERON:0001987 | 29.18 | gold quality |
| monocyte | CL:0000576 | 29.12 | gold quality |
| leukocyte | CL:0000738 | 28.98 | gold quality |
| tibial nerve | UBERON:0001323 | 28.98 | gold quality |
| right uterine tube | UBERON:0001302 | 28.74 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 28.39 | gold quality |
| kidney | UBERON:0002113 | 28.31 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 28.30 | gold quality |
| thoracic aorta | UBERON:0001515 | 28.16 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 28.10 | gold quality |
| ascending aorta | UBERON:0001496 | 28.05 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 27.50 | gold quality |
| minor salivary gland | UBERON:0001830 | 27.40 | gold quality |
| right atrium auricular region | UBERON:0006631 | 27.21 | silver quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 27.00 | gold quality |
| uterine cervix | UBERON:0000002 | 26.82 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 26.68 | gold quality |
| right coronary artery | UBERON:0001625 | 26.58 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 26.13 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| right testis | UBERON:0004534 | 25.82 | gold quality |
| adipose tissue | UBERON:0001013 | 25.36 | silver quality |
| body of stomach | UBERON:0001161 | 25.36 | gold quality |
| myometrium | UBERON:0001296 | 25.29 | gold quality |
| omental fat pad | UBERON:0010414 | 25.01 | silver quality |
| ectocervix | UBERON:0012249 | 24.95 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 24.89 | gold quality |
| prostate gland | UBERON:0002367 | 24.86 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 24.77 | gold quality |
| right lung | UBERON:0002167 | 24.76 | gold quality |
| left adrenal gland | UBERON:0001234 | 24.46 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 24.33 | gold quality |
| metanephros cortex | UBERON:0010533 | 24.06 | gold quality |
| colon | UBERON:0001155 | 24.03 | gold quality |
| esophagus mucosa | UBERON:0002469 | 24.02 | gold quality |
| endometrium | UBERON:0001295 | 23.81 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-137537 | yes | 5.64 |
| E-ANND-3 | no | 0.98 |
HPA expression
RNA tissue specificity: Tissue enriched
38 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Hippocampus | tissue | 32.5 |
| Cerebral cortex | tissue | 20.0 |
| Motor cortex | tissue | 20.0 |
| Amygdala | tissue | 14.1 |
| Substantia nigra | tissue | 14.0 |
| Hippocampal formation | tissue | 10.3 |
| Retrosplenial and cingulate cortex | tissue | 9.9 |
| Prefrontal cortex | tissue | 9.7 |
| Retrosplenial cortex | tissue | 9.7 |
| Hypothalamus | tissue | 9.0 |
| Postcentral gyrus | tissue | 8.1 |
| Nucleus accumbens | tissue | 7.6 |
| Periaqueductal gray | tissue | 7.5 |
| Insular cortex | tissue | 7.5 |
| Temporal cortex | tissue | 5.1 |
| Locus coeruleus | tissue | 4.7 |
| Septum | tissue | 4.6 |
| Somatosensory cortex | tissue | 4.2 |
| Pons | tissue | 3.8 |
| Midbrain | tissue | 3.5 |
| Corpus callosum | tissue | 3.5 |
| Ventral forebrain | tissue | 3.5 |
| Medulla oblongata | tissue | 3.2 |
| Retina | tissue | 2.7 |
| Entorhinal cortex | tissue | 2.7 |
| Occipital cortex | tissue | 2.5 |
| Thalamus | tissue | 2.4 |
| Superior colliculi | tissue | 2.1 |
| Spinal cord | tissue | 1.9 |
| Olfactory bulb | tissue | 1.7 |
| Putamen | tissue | 1.3 |
| Basal ganglia | tissue | 1.1 |
| Caudate putamen | tissue | 1.0 |
| Frontal cortex | tissue | 0.9 |
| Pituitary gland | tissue | 0.5 |
| Choroid plexus | tissue | 0.5 |
| Cerebellum | tissue | 0.4 |
| Lymph node | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 188; highest nTPM — Hippocampus, CA3 (48.7), Hippocampus, CA1 (41.4), Ventromedial nucleus (35.8), Dentate gyrus (30.8), Corticomedial amygdala (30.7).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting C1QL2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
10 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-214-5P | 97.34 | 66.50 | 617 |
| HSA-MIR-6748-3P | 97.20 | 65.66 | 836 |
| HSA-MIR-5702 | 96.68 | 68.21 | 958 |
| HSA-MIR-3677-5P | 93.16 | 64.62 | 393 |
Functional genomics
gnomAD constraint: pLI 6.22e-05, LOEUF 1.42, missense Z -0.458 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD)
ENST00000272520 splits into 2 regions with different missense tolerance; 0 are missense-constrained. Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD
| Region (GRCh38) | Missense obs / exp | o/e | Constrained |
|---|---|---|---|
| 2:119,156,805–119,156,975 | 43 / 74.8 | 0.57 | no |
| 2:119,156,976–119,158,269 | 353 / 334.8 | 1.05 | no |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | c1ql2 | ENSDARG00000015592 |
| mus_musculus | C1ql2 | ENSMUSG00000036907 |
| rattus_norvegicus | C1ql2 | ENSRNOG00000046863 |
Paralogs (23): C1QTNF3 (ENSG00000082196), COL19A1 (ENSG00000082293), PDCD7 (ENSG00000090470), COL10A1 (ENSG00000123500), C1QL1 (ENSG00000131094), C1QTNF6 (ENSG00000133466), COL8A1 (ENSG00000144810), C1QTNF2 (ENSG00000145861), C1QC (ENSG00000159189), C1QTNF7 (ENSG00000163145), C1QL3 (ENSG00000165985), COL8A2 (ENSG00000171812), C1QTNF4 (ENSG00000172247), C1QB (ENSG00000173369), C1QA (ENSG00000173372), C1QTNF1 (ENSG00000173918), ADIPOQ (ENSG00000181092), OTOL1 (ENSG00000182447), C1QTNF8 (ENSG00000184471), C1QL4 (ENSG00000186897), C1QTNF9B (ENSG00000205863), C1QTNF5 (ENSG00000223953), C1QTNF9 (ENSG00000240654)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:3032521) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 10 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal spleen morphology | 1 |
| impaired coordination | 1 |
| impaired balance | 1 |
| female infertility | 1 |
| abnormal motor capabilities/coordination/movement | 1 |
| abnormal kidney morphology | 1 |
| enlarged kidney | 1 |
| abnormal mitochondrial ATP synthesis coupled electron transport | 1 |
| abnormal oxidative phosphorylation | 1 |
| impaired fine motor coordination | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | P86437 | 100.0% | Diamond |
| Oryctolagus cuniculus | P14282 | 99.7% | Diamond |
| Gallus gallus | Q7LZR2 | 99.7% | Diamond |
| Oncorhynchus mykiss | A0A060WQA3 | 89.4% | Diamond |
| Oncorhynchus keta | P83371 | 89.4% | Diamond |
| Lepomis macrochirus | P98085 | 81.3% | Diamond |
| Sus scrofa | Q69DL0 | 78.5% | Diamond |
| Tamias sibiricus | Q06576 | 57.9% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| STEAP3-AS1 | ncRNA | 100874111 |
| STEAP3 | protein-coding | 55240 |
| MARCO | protein-coding | 8685 |
| LINC01956 | ncRNA | 124905956 |
| EN1 | protein-coding | 2019 |
Protein
Protein identifiers
Complement C1q-like protein 2 — Q7Z5L3 (reviewed: Q7Z5L3)
Alternative names: C1q and tumor necrosis factor-related protein 10
All UniProt accessions (2): A0A3B0IND4, Q7Z5L3
UniProt curated annotations — full annotation on UniProt →
Function. May regulate the number of excitatory synapses that are formed on hippocampus neurons. Has no effect on inhibitory synapses.
Subunit / interactions. Forms homotrimers which can further assemble to form higher-order oligomeric complexes. Interacts with ADGRB3. May interact with ERFE. Forms heterooligomers with C1QL3 and C1QL4, when proteins are coexpressed; this interaction does not occur after secretion.
Subcellular location. Secreted.
RefSeq proteins (1): NP_872334* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001073 | C1q_dom | Domain |
| IPR008160 | Collagen | Repeat |
| IPR008983 | Tumour_necrosis_fac-like_dom | Homologous_superfamily |
| IPR050822 | Cerebellin_Synaptic_Org | Family |
Pfam: PF00386, PF01391
UniProt features (8 total): domain 2, sequence conflict 2, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z5L3-F1 | 75.90 | 0.45 |
Human Protein Atlas
Protein class: Transporters, Accessory Factors Involved in Transport, Predicted secreted proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): vesicles; cytosol
Antibody reliability (HPA): IH uncertain · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 71 (showing top):
PAX4_01, GOBP_SYNAPSE_ASSEMBLY, GOCC_COLLAGEN_TRIMER, GOBP_CELLULAR_COMPONENT_MAINTENANCE, AP2_Q3, GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY, GOBP_CELL_CELL_SIGNALING, GOBP_CELL_JUNCTION_ORGANIZATION, AAAGACA_MIR511, GOBP_ORGANELLE_ASSEMBLY, GOBP_SYNAPTIC_SIGNALING, GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_CELL_JUNCTION_ASSEMBLY, GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE
GO Biological Process (5): regulation of synapse maturation (GO:0090128), postsynaptic density assembly (GO:0097107), trans-synaptic signaling, modulating synaptic transmission (GO:0099550), maintenance of synapse structure (GO:0099558), neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (7): protein-containing complex (GO:0032991), synaptic cleft (GO:0043083), synapse (GO:0045202), hippocampal mossy fiber to CA3 synapse (GO:0098686), cerebellar climbing fiber to Purkinje cell synapse (GO:0150053), extracellular region (GO:0005576), glutamatergic synapse (GO:0098978)
GO top-level categories
26 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| regulation of developmental process | 1 |
| regulation of synapse organization | 1 |
| synapse maturation | 1 |
| postsynaptic density organization | 1 |
| postsynaptic specialization assembly | 1 |
| excitatory synapse assembly | 1 |
| chemical synaptic transmission | 1 |
| modulation of chemical synaptic transmission | 1 |
| trans-synaptic signaling | 1 |
| cell junction maintenance | 1 |
| synapse organization | 1 |
| protein-containing complex localization | 1 |
| receptor localization to synapse | 1 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 1 |
| protein localization to postsynaptic specialization membrane | 1 |
| protein binding | 1 |
| binding | 1 |
| cellular_component | 1 |
| extracellular region | 1 |
| cell junction | 1 |
| thorny excrescence | 1 |
| neuron to neuron synapse | 1 |
| hippocampal mossy fiber expansion | 1 |
| asymmetric, glutamatergic, excitatory synapse | 1 |
| synapse | 1 |
Protein interactions and networks
STRING
showing 15 of 800 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C1QL2 | BEND5 | Q7L4P6 | 530 |
| C1QL2 | ADGRB3 | O60242 | 514 |
| C1QL2 | DPY19L4 | Q7Z388 | 468 |
| C1QL2 | TMEM9B | Q9NQ34 | 441 |
| C1QL2 | CCNQ | Q8N1B3 | 440 |
| C1QL2 | FIBCD1 | Q8N539 | 434 |
| C1QL2 | SLC45A1 | Q9Y2W3 | 431 |
| C1QL2 | KCTD20 | Q7Z5Y7 | 425 |
| C1QL2 | HABP4 | Q5JVS0 | 422 |
| C1QL2 | SPOCK1 | Q08629 | 407 |
| C1QL2 | NRXN2 | Q9P2S2 | 406 |
| C1QL2 | KCNH4 | Q9UQ05 | 404 |
| C1QL2 | NXPH4 | O95158 | 400 |
| C1QL2 | MPPED1 | O15442 | 399 |
| C1QL2 | NRXN1 | Q9ULB1 | 399 |
IntAct
BioGRID (1 interactions; top human partners by supporting records): BAI3 (Affinity Capture-MS)
Ligand–receptor pairs (CellPhoneDB) (1)
Curated ligand–receptor partners (cell-cell communication), distinct from the protein–protein interactions above.
1 ligand–receptor pairs:
| Partner | This gene’s role | Signaling class |
|---|---|---|
| ADGRB3 | ligand | Signaling by Complement |
Disease & clinical
Genetic variants
Variant evidence for C1QL2: 46 ClinVar records (5 pathogenic / likely pathogenic); 2 GWAS associations. Per-variant detail is on Sugi Variant.
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 4 |
| Likely pathogenic | 1 |
| Uncertain significance | 38 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (5)
Showing all 5 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 1809385 | GRCh37/hg19 2q14.1-14.3(chr2:116761476-123897262)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 4755368 | GRCh38/hg38 2q14.1-14.3(chr2:115987911-123142972)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 3062627 | GRCh37/hg19 2q14.1-14.3(chr2:116646793-126388760)x1 | Likely pathogenic | criteria provided, single submitter | 1 |
| 155658 | GRCh38/hg38 2q14.2-14.3(chr2:118687829-121621814)x1 | Pathogenic | no assertion criteria provided | 1 |
| 442443 | GRCh37/hg19 2q14.1-14.3(chr2:116754600-123897370)x1 | Pathogenic | no assertion criteria provided | 1 |
Per-variant reference — Sugi Variant
Explore C1QL2’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 18 predictions of 195):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 2:119156982–119156983 | acceptor_loss | 1.0000 | 5 |
| 2:119156982 | acceptor_loss | 0.9900 | |
| 2:119157584–119157585 | donor_loss | 0.9900 | 5 |
| 2:119157588 | donor_gain | 0.9900 | |
| 2:119157411 | donor_gain | 0.9400 | |
| 2:119156990 | acceptor_gain | 0.9200 | |
| 2:119157584 | donor_loss | 0.9100 | |
| 2:119157121 | donor_gain | 0.8800 | |
| 2:119157130 | donor_gain | 0.8700 | |
| 2:119156994 | acceptor_gain | 0.8600 |
AlphaMissense
997 missense substitutions predicted likely pathogenic (of 1,856 scored), across 183 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M211 | 9 | 0.990 | 1.000 |
| M219 | 9 | 0.977 | 1.000 |
| M31 | 9 | 0.900 | 0.988 |
| M25 | 9 | 0.872 | 0.980 |
| D237 | 8 | 0.999 | 1.000 |
| D243 | 8 | 0.999 | 1.000 |
| D222 | 8 | 0.998 | 1.000 |
| D264 | 8 | 0.998 | 1.000 |
| F205 | 8 | 0.997 | 1.000 |
| D215 | 8 | 0.997 | 1.000 |
| F279 | 8 | 0.997 | 1.000 |
| F161 | 8 | 0.996 | 1.000 |
| D239 | 8 | 0.996 | 1.000 |
| H269 | 8 | 0.996 | 1.000 |
| S218 | 8 | 0.995 | 1.000 |
| S232 | 8 | 0.995 | 1.000 |
| D257 | 8 | 0.995 | 1.000 |
| N274 | 8 | 0.994 | 1.000 |
| F177 | 8 | 0.992 | 1.000 |
| D179 | 8 | 0.989 | 0.998 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Lung Adenocarcinoma)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Lung Adenocarcinoma (TCGA) | favorable | 0.000944 |
Disease associations
OMIM: gene MIM:614330 | disease phenotypes:
GWAS associations
2 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST009391_236 | Metabolite levels | 7e-6 |
| GCST002688_3 | Very long-chain saturated fatty acid levels (fatty acid 22:0) | 8e-6 |
EFO canonical traits (from GWAS)
2 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0006796 | very long-chain saturated fatty acid measurement |
| EFO:0010424 | triacylglycerol 54:6 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aflatoxin B2 | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases reaction, increases expression | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Lipopolysaccharides | increases expression, decreases reaction | 1 |
| Malathion | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.